Literature DB >> 30101288

An Innovative Study Design to Assess the Community Effect of Interventions to Mitigate HIV Epidemics Using Transmission-Chain Phylodynamics.

Gkikas Magiorkinis1, Timokratis Karamitros2, Tetyana I Vasylyeva3, Leslie D Williams4, Jean L Mbisa5, Angelos Hatzakis1, Dimitrios Paraskevis1, Samuel R Friedman4.   

Abstract

Given globalization and other social phenomena, controlling the spread of infectious diseases has become an imperative public health priority. A plethora of interventions that in theory can mitigate the spread of pathogens have been proposed and applied. Evaluating the effectiveness of such interventions is costly and in many circumstances unrealistic. Most important, the community effect (i.e., the ability of the intervention to minimize the spread of the pathogen from people who received the intervention to other community members) can rarely be evaluated. Here we propose a study design that can build and evaluate evidence in support of the community effect of an intervention. The approach exploits molecular evolutionary dynamics of pathogens in order to track new infections as having arisen from either a control or an intervention group. It enables us to evaluate whether an intervention reduces the number and length of new transmission chains in comparison with a control condition, and thus lets us estimate the relative decrease in new infections in the community due to the intervention. We provide as an example one working scenario of a way the approach can be applied with a simulation study and associated power calculations.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30101288      PMCID: PMC6269241          DOI: 10.1093/aje/kwy160

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  24 in total

1.  The molecular clock of HIV-1 unveiled through analysis of a known transmission history.

Authors:  T Leitner; J Albert
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

2.  Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles.

Authors:  Ian Shrier; Jean-François Boivin; Russell J Steele; Robert W Platt; Andrea Furlan; Ritsuko Kakuma; James Brophy; Michel Rossignol
Journal:  Am J Epidemiol       Date:  2007-08-21       Impact factor: 4.897

3.  Big Events in Greece and HIV Infection Among People Who Inject Drugs.

Authors:  Georgios K Nikolopoulos; Vana Sypsa; Stefanos Bonovas; Dimitrios Paraskevis; Melpomeni Malliori-Minerva; Angelos Hatzakis; Samuel R Friedman
Journal:  Subst Use Misuse       Date:  2015-02-27       Impact factor: 2.164

4.  The Flawed Reliance on Randomized Controlled Trials in Studies of HIV Behavioral Prevention Interventions for People Who Inject Drugs and Other Populations.

Authors:  Samuel R Friedman; David C Perlman; Danielle C Ompad
Journal:  Subst Use Misuse       Date:  2015-07-29       Impact factor: 2.164

5.  Molecular Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Individuals in a Network-Based Intervention (Transmission Reduction Intervention Project): Phylogenetics Identify HIV-1-Infected Individuals With Social Links.

Authors:  Evangelia-Georgia Kostaki; Georgios K Nikolopoulos; Eirini Pavlitina; Leslie Williams; Gkikas Magiorkinis; John Schneider; Britt Skaathun; Ethan Morgan; Mina Psichogiou; Georgios L Daikos; Vana Sypsa; Pavlo Smyrnov; Ania Korobchuk; Meni Malliori; Angelos Hatzakis; Samuel R Friedman; Dimitrios Paraskevis
Journal:  J Infect Dis       Date:  2018-07-24       Impact factor: 5.226

Review 6.  HIV treatment as prevention: considerations in the design, conduct, and analysis of cluster randomized controlled trials of combination HIV prevention.

Authors:  Marie-Claude Boily; Benoît Mâsse; Ramzi Alsallaq; Nancy S Padian; Jeffrey W Eaton; Juan F Vesga; Timothy B Hallett
Journal:  PLoS Med       Date:  2012-07-10       Impact factor: 11.069

7.  Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone--Indiana, 2015.

Authors:  Caitlin Conrad; Heather M Bradley; Dita Broz; Swamy Buddha; Erika L Chapman; Romeo R Galang; Daniel Hillman; John Hon; Karen W Hoover; Monita R Patel; Andrea Perez; Philip J Peters; Pam Pontones; Jeremy C Roseberry; Michelle Sandoval; Jessica Shields; Jennifer Walthall; Dorothy Waterhouse; Paul J Weidle; Hsiu Wu; Joan M Duwve
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-05-01       Impact factor: 17.586

8.  Simulations for designing and interpreting intervention trials in infectious diseases.

Authors:  M Elizabeth Halloran; Kari Auranen; Sarah Baird; Nicole E Basta; Steven E Bellan; Ron Brookmeyer; Ben S Cooper; Victor DeGruttola; James P Hughes; Justin Lessler; Eric T Lofgren; Ira M Longini; Jukka-Pekka Onnela; Berk Özler; George R Seage; Thomas A Smith; Alessandro Vespignani; Emilia Vynnycky; Marc Lipsitch
Journal:  BMC Med       Date:  2017-12-29       Impact factor: 8.775

9.  The global spread of HIV-1 subtype B epidemic.

Authors:  Gkikas Magiorkinis; Konstantinos Angelis; Ioannis Mamais; Aris Katzourakis; Angelos Hatzakis; Jan Albert; Glenn Lawyer; Osamah Hamouda; Daniel Struck; Jurgen Vercauteren; Annemarie Wensing; Ivailo Alexiev; Birgitta Åsjö; Claudia Balotta; Perpétua Gomes; Ricardo J Camacho; Suzie Coughlan; Algirdas Griskevicius; Zehava Grossman; Anders Horban; Leondios G Kostrikis; Snjezana J Lepej; Kirsi Liitsola; Marek Linka; Claus Nielsen; Dan Otelea; Roger Paredes; Mario Poljak; Elizabeth Puchhammer-Stöckl; Jean Claude Schmit; Anders Sönnerborg; Danica Staneková; Maja Stanojevic; Dora C Stylianou; Charles A B Boucher; Georgios Nikolopoulos; Tetyana Vasylyeva; Samuel R Friedman; David van de Vijver; Gioacchino Angarano; Marie-Laure Chaix; Andrea de Luca; Klaus Korn; Clive Loveday; Vincent Soriano; Sabine Yerly; Mauricio Zazzi; Anne-Mieke Vandamme; Dimitrios Paraskevis
Journal:  Infect Genet Evol       Date:  2016-06-02       Impact factor: 3.342

10.  Estimating time of HIV-1 infection from next-generation sequence diversity.

Authors:  Vadim Puller; Richard Neher; Jan Albert
Journal:  PLoS Comput Biol       Date:  2017-10-02       Impact factor: 4.475

View more
  5 in total

1.  Phylodynamics Helps to Evaluate the Impact of an HIV Prevention Intervention.

Authors:  Tetyana I Vasylyeva; Alexander Zarebski; Pavlo Smyrnov; Leslie D Williams; Ania Korobchuk; Mariia Liulchuk; Viktoriia Zadorozhna; Georgios Nikolopoulos; Dimitrios Paraskevis; John Schneider; Britt Skaathun; Oliver G Pybus; Samuel R Friedman
Journal:  Viruses       Date:  2020-04-20       Impact factor: 5.048

2.  Prevalence of Non-B HIV-1 Subtypes in North Italy and Analysis of Transmission Clusters Based on Sequence Data Analysis.

Authors:  Giovanni Lorenzin; Franco Gargiulo; Arnaldo Caruso; Francesca Caccuri; Emanuele Focà; Anna Celotti; Eugenia Quiros-Roldan; Ilaria Izzo; Francesco Castelli; Maria A De Francesco
Journal:  Microorganisms       Date:  2019-12-23

3.  Spatiotemporal Distribution and Genetic Characterization of Measles Strains Circulating in Greece during the 2017-2018 Outbreak.

Authors:  Vasiliki Pogka; Elina Horefti; Maria Evangelidou; Evangelia Georgia Kostaki; Dimitrios Paraskevis; Anastasia Flountzi; Theano Georgakopoulou; Ioanna Magaziotou; Andreas Mentis; Timokratis Karamitros
Journal:  Viruses       Date:  2020-10-15       Impact factor: 5.048

4.  Impact of technological developments on infectious disease epidemiology: Lessons from the first 100 years of AJE.

Authors:  Betsy Foxman; Shruti Mehta
Journal:  Am J Epidemiol       Date:  2022-03-31       Impact factor: 5.363

5.  SARS-CoV-2 exhibits intra-host genomic plasticity and low-frequency polymorphic quasispecies.

Authors:  Timokratis Karamitros; Gethsimani Papadopoulou; Maria Bousali; Anastasios Mexias; Sotirios Tsiodras; Andreas Mentis
Journal:  J Clin Virol       Date:  2020-08-11       Impact factor: 3.168

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.